SCHEMBL8265306

SCHEMBL8265306

CC(C)COc1ccc(Br)cc1CNc1cccnc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 5/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ APAF1 O14727 2/20 0.43
▸ BLM P54132 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ CCR5 P51681 2/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TLR8 Q9NR97 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ HTT P42858 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8264443 0.87 KMT2A (0.48) BACE1MEN1KMT2AAPAF1BLM
SCHEMBL8265529 0.82 MEN1 (0.54) BACE1MEN1KMT2AAPAF1BLM
SCHEMBL8265568 0.82 BACE1 (0.44) BACE1MEN1KMT2AAPAF1BLM
SCHEMBL8264446 0.82 BACE1 (0.63) BACE1CCR5ALDH1A1RAB9ALMNA
SCHEMBL14007503 0.81 BACE1 (0.64) BACE1MEN1KMT2AAPAF1CCR5
SCHEMBL14007515 0.79 MEN1 (0.53) BACE1MEN1KMT2ACCR5ALDH1A1
SCHEMBL8265215 0.78 BACE1 (0.45) BACE1MEN1KMT2AAPAF1POLB
SCHEMBL8264988 0.76 MEN1 (0.40) BACE1MEN1KMT2AAPAF1BLM
SCHEMBL10643589 0.70 LTA4H (0.54) L3MBTL1ALDH1A1RAB9ATLR8LMNA
SCHEMBL23275541 0.69 ALDH1A1 (0.51) MEN1KMT2ACCR5ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287399-A1 Substituted Aminopyridines and Uses Thereof ASTRAZENECA AB (SE) 2008-11-20 — — US disclosed
US-20080287399-A1 Substituted Aminopyridines and Uses Thereof ASTRAZENECA AB (SE) 2008-11-20 — — US disclosed
WO-2006065204-A1 SUBSTITUTED AMINOPYRIDINES AND USES THEREOF ASTRAZENECA AB (SE) 2006-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287399-A1 Substituted Aminopyridines and Uses Thereof PSEN2, SLC1A2, PSEN1 BACE1 30/4885MEN1 3533/4885KMT2A 1883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback